Longevity & AgingHeart Muscle Patches Show Early Promise for Restoring Failing Hearts
Researchers have developed engineered heart muscle patches — called BioVAT — that can be surgically attached to a failing heart to replace lost muscle cells. In a small early-stage study of 20 patients with advanced heart failure, those receiving the maximum dose showed measurable improvements in heart wall thickness, pumping function (ejection fraction), and quality of life after just three months. Unlike drugs or devices, BioVAT aims to physically rebuild heart muscle using stem-cell-derived cardiomyocytes. This is significant because the adult heart cannot naturally regenerate lost muscle cells, and current treatments only slow decline rather than repair damage. While promising, this is a phase I-II trial — safety and long-term efficacy questions remain open.
